相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Importance of IL-10 and IL-6 during chronic hepatitis c genotype-1 treatment and their relation with IL28B
Esther-J. Pavon-Castillero et al.
CYTOKINE (2013)
Cytokines genes polymorphisms in chronic hepatitis C: Impact on susceptibility to infection and response to therapy
Heba F. Pasha et al.
CYTOKINE (2013)
Increased Baseline Proinflammatory Cytokine Production in Chronic Hepatitis C Patients with Rapid Virological Response to Peginterferon Plus Ribavirin
Gabriella Par et al.
PLOS ONE (2013)
A Single Nucleotide Polymorphism Associated with Hepatitis C Virus Infections Located in the Distal Region of the IL28B Promoter Influences NF-κB-Mediated Gene Transcription
Sreedhar Chinnaswamy et al.
PLOS ONE (2013)
Cytokines and HCV-Related Disorders
Poupak Fallahi et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates
Kui Li et al.
HEPATOLOGY (2012)
Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C
Takeji Umemura et al.
ANTIVIRAL THERAPY (2011)
Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
Suguru Yoneda et al.
HEPATOLOGY RESEARCH (2011)
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
Armanda Casrouge et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients
Suguru Yoneda et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms
Martin Lagging et al.
PLOS ONE (2011)
Activation of brain macrophages/microglia cells in hepatitis C infection
Jeffrey Wilkinson et al.
GUT (2010)
Histologic Outcomes in Hepatitis C-Infected Patients with Varying Degrees of Virologic Response to Interferon-Based Treatments
Paul J. Pockros et al.
HEPATOLOGY (2010)
IL28B Genotype Is Associated With Differential Expression of Intrahepatic Interferon-Stimulated Genes in Patients With Chronic Hepatitis C
Thomas J. Urban et al.
HEPATOLOGY (2010)
Chemokines in the Immunopathogenesis of Hepatitis C Infection
Mathis Heydtmann et al.
HEPATOLOGY (2009)
Early Gene Expression Profiles of Patients with Chronic Hepatitis C Treated with Pegylated Interferon-Alfa and Ribavirin
Zobair M. Younossi et al.
HEPATOLOGY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Review: Predicting the probable outcome of treatment in HCV patients
Udayakumar Navaneethan et al.
Therapeutic Advances in Gastroenterology (2009)
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial
Ming-Lung Yu et al.
HEPATOLOGY (2008)
Peripheral Blood Gene Expression Profile Associated with Sustained Virologic Response after Peginterferon Plus Ribavirin Therapy for Chronic Hepatitis-C Genotype 1
Chao Huang et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION (2008)
The kinetics of hepatitis C virus-specific CD8 T-cell responses in the blood mirror those in the liver in acute hepatitis C virus infection
Eui-Cheol Shin et al.
JOURNAL OF VIROLOGY (2008)
Interferon signaling and treatment outcome in chronic hepatitis C
Magdalena Sarasin-Filipowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Antiviral action of interferon-α against hepatitis C virus replicon and its modulation by interferon-γ and interleukin-8
Yintang Jia et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Chemokines in hepatitis C virus infection: Pathogenesis, prognosis and therapeutics
Ori Wald et al.
CYTOKINE (2007)
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
Martin Lagging et al.
HEPATOLOGY (2006)
Toll-like receptor signaling in the liver
Robert F. Schwabe et al.
GASTROENTEROLOGY (2006)
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection
A Gramenzi et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
D Butera et al.
BLOOD (2005)
Global effect of PEG-IFN-α and ribavirin on gene expression in PBMC in vitro
MW Taylor et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2004)
Outcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases
CK Hui et al.
GUT (2003)
Liver-infiltrating lymphocytes in end-stage hepatitis C virus: Subsets, activation status, and chemokine receptor phenotypes
J Boisvert et al.
JOURNAL OF HEPATOLOGY (2003)
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease
R Thimme et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Adherence to combination therapy enhances sustained response in genotyp-1-infected patients with chronic hepatitis C
JG McHutchison et al.
GASTROENTEROLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection
S Sobue et al.
JOURNAL OF GASTROENTEROLOGY (2001)
Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers
F Lechner et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2000)